Pfizer (NYSE:PFE) is a global pharmaceutical giant that has long been a cornerstone of medical innovation and today boasts a ...

Analysts exoect revenue to rise by more than 180%, to $762 million, this year, and then grow another 45%, to $1.1 billion, next year, pushing the biotech company out of the red and into the black ...

With its patented, AI-powered, FDA-certified transmission X-ray technology, since 2007 NanoRay Biotech is radically transforming medical and industrial X-ray applications in Taiwan and aims to further ...

Combining pioneering iPSC technology and patented live cell bioimaging, LumiSTAR is opening up exciting new possibilities in the treatment of various diseases and the development of innovative new dru ...

greater control over the biotech company’s operations. Pete Salzmann, Immunovant’s current CEO and board member, is retiring. He will be replaced by Eric Venker, Roivant’s current president ...

This purchase signals a growing interest in the established biotech company, known for its innovative treatments and steady market presence. Continuing its investment in the sector, ARK also ...

Tilt your stock portfolio toward biotech companies now and you could stand to make substantial profits in the near future. You can also find cost-effective stocks under $20 to trade daily on the ...

Novo Nordisk has agreed its second acquisition in the space of a month of a biotech in the obesity category, snapping up fellow Danish company Embark Biotech for €15 million (around $16 million ...

1 SAN DIEGO, March 27, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq:ONVO) (“Organovo” or the “Company”), a clinical stage biotechnology company focused on developing novel ...

In a more recent escalation of this confrontation, the BIOSECURE Act was tabled in the US, which aims to prevent the contracting or extension of loans and grants with a “biotechnology company of ...

Its parent company, HD Hyundai, partnered with US-based artificial intelligence leader Palantir in 2024 for the development of uncrewed vessels, marking the beginning of its involvement in the ...

In this article, we take a look at seven biotech companies with clinical drug candidates on a quest to win regulatory approval to treat hepatitis B. Chronic HBV infection is the leading cause of ...